On May 2, 2025 the CEO of BioPortUSA, Mark Lesselroth, will be presenting to Health Founders, a launchpad for ambitious founders who are building the future of health. Health Founders is the leading health technology accelerator in Estonia. They help exceptional founders develop breakthrough ideas into sustainable business models.
The focus of the presentation is to provide an overview of the U.S. Healthcare market and what a foreign medtech company needs to do to assure successful commercialization. Keita Augstkalne, Community Manager for Health Founders,mentioned that “We’re excited to welcome:Mark Lesselroth, CEO & President of BioPortUSA
With extensive experience in the U.S. healthcare sector, Mark will share actionable insights on accelerating commercialization while navigating regulatory hurdles and optimizing cost-efficiency.”
The accelerator recognizes that the United States is a crucial but challenging landscape for healthtech start-ups out of Estonia.
Some of the topics we will touch on include: The importance of Market Research, both secondary and Primary. Why you should develop a commercialization Plan. FDA approval is a prerequisite for market entry. Without Reimbursement there are virtually no sales opportunities in the USA and the role that Branding plays in being able to successfully sell your technology in the United States.
For those interested in the event, visit LinkedIn:
Navigating Health Tech Across Boarders